MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202517068753 A) filed by Alphamol Science Ltd (SHANGHAI), Shanghai, on July 18, for 'new phenylquinolone compound having antibacterial and anti-cancer functions and preparation thereof.'
Inventor(s) include Yuan, Shuguang; Li, Haijian; Pan, Qing; and Qin, Taisheng.
The application for the patent was published on Sept. 12, under issue no. 37/2025.
According to the abstract released by the Intellectual Property India: "Disclosed in the present invention are a new phenylquinolone compound having antibacterial and anti-cancer functions and the preparation thereof, which belong to the technical field of medicines. Provided in the present invention is a phenylquinolone compound as represented by formula (I) having antibacterial and anti-cancer activities or a pharmaceutically acceptable salt, a stereoisomer, a deuterated compound or a prodrug thereof. Also provided in the present invention is an antibacterial composition containing one or more compounds of formula (I) or salts thereof. The present invention further comprises a method for treating and preventing bacterial infections and the growth of tumor cells by means of administering several effective doses of the compounds of formula (I) or salts thereof."
The patent application was internationally filed on Feb. 23, 2024, under International application No.PCT/CN2024/078241.
Disclaimer: Curated by HT Syndication.
